Contemporary Considerations for Constructing a Genetic Risk Score: An Empirical Approach
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Genetic risk scores are an increasingly popular tool for summarizing the cumulative risk of a set of Single Nucleotide Polymorphisms (SNPs) with disease. Typically only the set of the SNPs that have reached genome‐wide significance compose these scores. However recent work suggests that including additional SNPs may aid risk assessment. In this paper, we used the Atherosclerosis Risk in Communities (ARIC) Study cohort to illustrate how one can choose the optimal set of SNPs for a genetic risk score (GRS). In addition to P‐value threshold, we also examined linkage disequilibrium, imputation quality, and imputation type. We provide a variety of evaluation metrics. Results suggest that P‐value threshold had the greatest impact on GRS quality for the outcome of coronary heart disease, with an optimal threshold around 0.001. However, GRSs are relatively robust to both linkage disequilibrium and imputation quality. We also show that the optimal GRS partially depends on the evaluation metric and consequently the way one intends to use the GRS. Overall the implications highlight both the robustness of GRS and a means to empirically choose the best set of GRSs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1229 · Cited by 2,707 · cited 3×
“Genome-wide association studies (GWAS) and follow-up meta-analyses have identified a plethora of susceptibility loci for many different common diseases [Welter et al., 2014].”
BackgroundVisscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425 · cited 2×
“…number of polymorphisms reaching genomewide significance remains modest, typically <100 per disease, simulation and empirical studies suggest that many more common susceptibility variants remain to be discovered [Stahl et al., 2012; Visscher et al., 2012; Welter et al., 2014; Wray et al., 2011].”
BackgroundLarge-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Self-citationMaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
Li, Y., Willer, C. J., Ding, J., Scheet, P., & Abecasis, G. R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20533 · Cited by 1,843
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. (2012) · Nature Genetics · doi:10.1038/ng.2354 · Cited by 1,737 · cited 1×
“We used MACH and Minimac to phase and impute the individual-level genotype data from ARIC to the latest build of the 1000 genomes project to minimize the need to search for and use proxies used in the construction of the GRS [Howie et al., 2012; Li et al., 2010].”
MethodUsing multiple genetic variants as instrumental variables for modifiable risk factors
Palmer, T. M., Lawlor, D. A., Harbord, R. M., Sheehan, N. A., Tobias, J. H., Timpson, N. J., Smith, G. D., & Sterne, J. A. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280210394459 · Cited by 1,289 · cited 2×
“, 2009], Mendelian randomization studies [Palmer et al., 2012], and risk prediction [Weijmans et al.”
BackgroundData and Theory Point to Mainly Additive Genetic Variance for Complex Traits
Hill, W. G., Goddard, M. E., & Visscher, P. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000008 · Cited by 1,039
Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis
Diabetes Genetics Replication and Meta-analysis Consortium, Stahl, E. A., Myocardial Infarction Genetics Consortium, Wegmann, D., Trynka, G., Gutierrez-Achury, J., Do, R., Voight, B. F., Kraft, P., Chen, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.2232 · Cited by 388 · cited 2×
“…number of polymorphisms reaching genomewide significance remains modest, typically <100 per disease, simulation and empirical studies suggest that many more common susceptibility variants remain to be discovered [Stahl et al., 2012; Visscher et al., 2012; Welter et al., 2014; Wray et al., 2011].”
BackgroundThanassoulis, G., Peloso, G. M., Pencina, M. J., Hoffmann, U., Fox, C. S., Cupples, L. A., Levy, D., D'Agostino, R. B., Hwang, S.-J., & O'Donnell, C. J. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961342 · Cited by 211 · cited 1×
“To date, GRSs have been created for many complex diseases, including cardiovascular disease [Thanassoulis et al., 2012], schizophrenia [Purcell et al., 2009], and multiple sclerosis [De Jager et al., 2009].”
MethodSynthetic Associations Created by Rare Variants Do Not Explain Most GWAS Results
Wray, N. R., Purcell, S. M., & Visscher, P. M. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000579 · Cited by 176 · cited 2×
“…number of polymorphisms reaching genomewide significance remains modest, typically <100 per disease, simulation and empirical studies suggest that many more common susceptibility variants remain to be discovered [Stahl et al., 2012; Visscher et al., 2012; Welter et al., 2014; Wray et al., 2011].”
Background
Cited by
Genomic prediction of coronary heart disease
Abraham, G., Havulinna, A. S., Bhalala, O. G., Byars, S. G., De Livera, A. M., Yetukuri, L., Tikkanen, E., Perola, M., Schunkert, H., Sijbrands, E. J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw450 · Cited by 338
Privacy risks from genomic data-sharing beacons
Shringarpure, S. S., & Bustamante, C. D. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.09.010 · Cited by 211
Heterogeneity in polygenic scores for common human traits
Ware, E. B., Schmitz, L. L., Faul, J., Gard, A., Mitchell, C., Smith, J. A., Zhao, W., Weir, D., & Kardia, S. L. (2017) · doi:10.1101/106062 · Cited by 123
“001 (18, 19) – though these thresholds were optimal only for the trait or type of trait analyzed (binary trait with prevalence of 10% (18), coronary heart disease (19).”
Background
Metadata
- Authors
- Goldstein, B. A., Yang, L., Salfati, E., & Assimes, T. L.
- Venue
- Genetic Epidemiology
- Publisher
- Wiley
- Published
- 2015-07-22
- Volume
- 39
- Issue
- 6
- Pages
- 439-445
- ISSN
- 0741-0395 (ISSN-L)
- 1098-2272
- OpenAlex
- W1488170387
- Cited by
- 46
- References
- 11
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.